A phase Ib/II trial of capmatinib plus spartalizumab vs. spartalizumab alone in patients with pretreated hepatocellular carcinoma - Santoro, Armando; Assenat, Éric; Yau, Thomas; Delord, Jean-Pierre; Maur, Michela; Knox, Jennifer; Cattan, Stephane; Lee, Kyung-Hun; Del Conte, Gianluca; Springfeld, Christoph; Leo, Elisa; Xyrafas, Alexandros; et al. (JHEP reports, 2024)
Gesehen am 05.12.2024